Developing therapeutics for diseases with impaired kidney function Tue, 24 Aug 2021 13:15:37 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 https://i0.wp.com/www.enyopharma.com/wp-content/uploads/2016/02/cropped-enyo_pharma_large_app_icon.png?fit=32%2C32&ssl=1 32 32 231983735 /fierce-biotech-enyo-pharmas-nash-results-show-boost-in-kidney-function-differentiating-vonafexor-from-busy-field/ Thu, 29 Jul 2021 13:10:42 +0000 http://www.enyopharma.com/?p=3856

]]> 3856 /lyon-decideurs-enquete-lyon-paradis-pour-les-biotechs/ Mon, 15 Mar 2021 13:16:03 +0000 http://www.enyopharma.com/?p=3649 Our CEO Jacky Vonderscher has been interviewed in Maxime Feuillet’s feature on biotechs that have found their paradise in Lyon.

]]> 3649 /la-tribune-la-startup-de-la-semaine-comment-enyo-pharma-espere-guerir-lhepatite-b/ Fri, 10 Jan 2020 16:02:15 +0000 http://www.enyopharma.com/fr/?p=3398

]]> 3398 /2968/ Tue, 18 Dec 2018 15:27:43 +0000 http://www.enyopharma.com/?p=2968

]]> 2968 /enyo-pharma-start-up-de-lannee-en-auvergne-rhone-alpes/ Wed, 19 Sep 2018 08:19:23 +0000 http://www.enyopharma.com/?p=2568

]]> 2568 /labiotech-french-biotech-raises-e40m-to-fight-hepatitis-b-and-nash/ Tue, 05 Jun 2018 13:48:19 +0000 http://www.enyopharma.com/?p=2375

]]> 2375 /biocentury-enyo-aims-for-phase-ii-hbv-nash-trials-with-e40m-round/ Tue, 05 Jun 2018 11:26:38 +0000 http://www.enyopharma.com/?p=2373

]]> 2373 /le-journal-des-entreprises-levee-de-fonds-record-de-40-millions-deuros-pour-enyo-pharma/ Tue, 05 Jun 2018 08:38:40 +0000 http://www.enyopharma.com/?p=2364

]]> 2364 /les-echos-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash/ Tue, 05 Jun 2018 08:29:23 +0000 http://www.enyopharma.com/?p=2362

]]> 2362 /fierce-biotech-enyo-pharma-raises-47m-to-bring-hepatitis-b-nash-drug-to-phase-2/ Tue, 05 Jun 2018 08:23:08 +0000 http://www.enyopharma.com/?p=2354

]]> 2354